A detailed history of Israel Englander (Millennium Management LLC) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,986,548 shares of ABEO stock, worth $8.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,986,548
Previous 1,418,675 40.03%
Holding current value
$8.7 Million
Previous $7.11 Million 102.65%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $2.31 Million - $4.93 Million
567,873 Added 40.03%
1,986,548 $14.4 Million
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $2.69 Million - $3.73 Million
725,704 Added 104.72%
1,418,675 $7.11 Million
Q2 2023

Aug 14, 2023

BUY
$2.76 - $5.27 $1.42 Million - $2.71 Million
515,016 Added 289.41%
692,971 $2.79 Million
Q1 2023

May 15, 2023

BUY
$2.25 - $3.27 $67,896 - $98,675
30,176 Added 20.42%
177,955 $502,000
Q4 2022

Feb 14, 2023

BUY
$2.4 - $4.39 $354,669 - $648,749
147,779 New
147,779 $455,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $26.1M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.